Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masding, M. G.
Right arrow Articles by Sandeman, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masding, M. G.
Right arrow Articles by Sandeman, D. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:3243-3249, 2003
© 2003 by the American Diabetes Association, Inc.


Epidemiology/Health Services/Psychosocial Research
Original Article

Premenopausal Advantages in Postprandial Lipid Metabolism Are Lost in Women With Type 2 Diabetes

Michael G. Masding, MBBS, MRCP1,2, Anna J. Stears, MBBS, MRCP1,2, Graham C. Burdge, PHD2, Stephen A. Wootton, PHD2 and Derek D. Sandeman, BSC, MBBS, FRCP1

1 Southampton University Hospitals NHS Trust, Southampton, U.K
2 Institute of Human Nutrition, University of Southampton, Southampton, U.K

Address correspondence and reprint requests to Dr. Mike Masding, Specialist Registrar in Diabetes & Endocrinology, Poole Hospital NHS Trust, Longfleet Road, Poole BH15 2JB, U.K. E-mail: mike.mas{at}lineone.net

OBJECTIVE—Women with type 2 diabetes appear to lose the protection against cardiovascular disease afforded by estrogens. We examined the effects of menopausal status on postprandial clearance of dietary fat in healthy and diabetic women.

RESEARCH DESIGN AND METHODS—Fasting subjects (premenopausal and postmenopausal control subjects, premenopausal and postmenopausal diabetic women, all n = 8) were given a meal containing the stable isotope 1,1,1-13C-tripalmitin, with blood and breath sampled for 6 and 24 h, respectively, in the postprandial period. Lower levels of 13C-palmitic acid (13C-PA) in the triglyceride fraction implies more efficient chylomicron clearance, lower levels of 13C-PA in the nonesterified fatty acid (NEFA) fraction implies improved dietary NEFA entrapment, and higher levels of 13CO2 in the breath denote more efficient of oxidation of dietary-derived lipid.

RESULTS—In diabetic women, there were no differences between the pre- and postmenopausal groups for any of these parameters. In contrast, premenopausal control subjects, compared with postmenopausal control subjects, had lower 13C-PA in the triglyceride fraction area under the curve (AUC) (premenopausal median [range] 25.2 [12.1–49.4 mmol/l] per 6 h, postmenopausal 48.5 [15.5–77.2 mmol/l] per 6 h; P < 0.01) and higher 13CO2 levels in the breath AUC (premenopausal 22.5 [18.0–31.5%] of administered dose, postmenopausal 17.2 [11.2–31.5%] of administered dose; P < 0.01) with no difference between groups in levels of 13C-PA in the NEFA fraction AUC.

CONCLUSIONS—The premenopausal advantage in clearance of dietary lipid is not seen in premenopausal diabetic women. This is likely to promote an atherogenic lipoprotein profile and may contribute to the loss of cardiovascular disease protection seen in diabetic women.

Abbreviations: AUC, area under the curve • CHD, coronary heart disease • IRMS, isotope ratio mass spectrometry • LPL, lipoprotein lipase • NEFA, nonesterified fatty acid • TRL, triglyceride-rich lipoprotein • 13C-PA, 13C-palmitic acid


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
D. B. Carr, K. M. Utzschneider, R. L. Hull, J. Tong, T. M. Wallace, K. Kodama, J. B. Shofer, S. R. Heckbert, E. J. Boyko, W. Y. Fujimoto, et al.
Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.
Diabetes Care, September 1, 2006; 29(9): 2078 - 2083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.